ATG7, an activator of ATG8 involved in the expansion of phagophore, confers chemoresistance in the acute myeloid leukemia cell lines against cytarabine and idarubicin treatment, knockdown of ATG7 increased apoptosis and DNA damage (Piya et al., 2016). Here, ATG7 is linked to acute myeloid leukemia.